Phio Pharmaceuticals to present at NIBA 153rd Conference, updates PH-762 program

PUBT · 2d ago
Phio Pharmaceuticals to present at NIBA 153rd Conference, updates PH-762 program
  • Phio Pharmaceuticals will present at NIBA’s 153rd Conference in Fort Lauderdale, Florida, on Oct. 6-7, 2026.
  • CEO Robert Bitterman is scheduled to present on Oct. 7, 2026 at 12:40 p.m. EDT.
  • Talk will cover the INTASYL siRNA platform, delivery approach, strategic direction, with a development update on PH-762 in cutaneous squamous cell carcinoma.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610050700NEWSFILECNPR____20261005_317275_1) on October 05, 2026, and is solely responsible for the information contained therein.